Related Experiment Video
Updated: Jun 9, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
Novel kidney injury biomarkers
1Division of Nephrology and Hypertension, Harbor-UCLA Medical Center, Torrance, California 90509, USA. sadler@LABiomed.org
Abstract:
New biomarkers are currently under development for acute kidney injury and chronic kidney disease. Panels of validated biomarkers are most likely to be required to obtain information that will help in delineating acute versus chronic disease, the pathogenetic nature of the process, the severity, and the capacity for reversibility. Glycoprotein non-metastatic melanoma protein-b, a protein associated with regulation of inflammation and autophagy, is in an intermediate stage of development as a kidney injury biomarker.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management

